Genomic & Biopharma News

AstraZeneca’s ASCO pledge? Be a better social media citizen
AstraZeneca changed its social media strategy for this year’s ASCO meeting, promising to do a better—and broader—job tweeting and posting from the conference.
Fierce Pharma, 2017-05-31 13:57:35

Stampeding generics expected to trample Lilly's now-off-patent ADHD med Strattera
Eli Lilly’s $500 million ADHD med Strattera has succumbed to generics. Four drugmakers won FDA green lights for their copycats, and the competitive pressure is expected to quickly tank the brand's sales.
Fierce Pharma, 2017-05-31 13:45:29

New study documents prevalence of food allergies
Anecdotal evidence of food allergies abounds, but just how common are these allergies and intolerances? In a new study, investigators from Brigham and Women's Hospital combed through medical records from more than 2.7 million patients, identifying more than 97,000 with one or more documented food allergy or intolerance.
News Medical Life Sciences, 2017-05-31 13:29:14

Researchers make significant advance in treatment of bowel cancer
New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
News Medical Life Sciences, 2017-05-31 13:17:27

WBD-SC launches new practical guidelines for effective treatment of bedwetting
The World Bedwetting Day Steering Committee has launched simplified practical guidelines to help healthcare professionals understand how best to treat bedwetting.
News Medical Life Sciences, 2017-05-31 13:12:49

BabyLux aims to reduce risk of brain lesions in extremely preterm babies
For the first time, two advanced biophotonic technologies – near-infrared time-resolved spectroscopy (TRS) and diffuse correlation spectroscopy (DCS) – have been combined and the already tested prototypes were extended to the level of demonstrators.
News Medical Life Sciences, 2017-05-31 13:11:57

Dutch scientists design self-destroying nanomotors to deliver and release drugs
Autonomous targeting and release of drugs at their site of action are desired features of nanomedical systems. Now, a team of Dutch scientists has designed a nanomotor that has these functions: An antitumor drug encapsulated in self-propelled, self-assembled stomatocytes is carried across the cellular membrane and released inside the cell upon a chemical redox signal that disassembles the vesicle membrane.
News Medical Life Sciences, 2017-05-31 13:11:09

Teva posts positive phase 3 migraine data, plots FDA submission
Israeli pharma Teva has hit its endpoints in the phase 3 Halo study of fremanezumab in migraines as it looks to send off a BLA to the FDA in the coming months.
Fierce Biotech, 2017-05-31 13:10:08

Sartorius Stedim Biotech launches next generation BIOSTAT STR bioreactors
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, announced the launch of its next generation BIOSTAT STR, a fully scalable, single-use bioreactor family based on a conventional stirred-tank design.
News Medical Life Sciences, 2017-05-31 13:07:08